Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 6 (2009), Issue 7 (July)

1. Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia.
   Qual Life Res, 18(6): 699-707. [Abstract] [Full-text]
2. Investigation of the cause of death in a gene-therapy trial.
   N Engl J Med, 361(2): 161-9. [Abstract] [Full-text]
3. Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.
   Clin Exp Med, 9(3): 223-8. [Abstract] [Full-text]
4. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis.
   Clin Exp Med, 9(3): 215-21. [Abstract] [Full-text]
5. Targeted ultrasound of the fifth metatarsophalangeal joint in an early inflammatory arthritis cohort.
   Arthritis Rheum, 61(7): 1004-8. [Abstract] [Full-text]
6. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
   Arthritis Rheum, 61(7): 979-87. [Abstract] [Full-text]
7. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations.
   Rheumatology (Oxford), 48(8): 972-7. [Abstract] [Full-text]
8. High-resolution ultrasound confirms reduced synovial hyperplasia following rituximab treatment in rheumatoid arthritis.
   Rheumatology (Oxford), 48(8): 939-43. [Abstract] [Full-text]
9. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
   Rheumatology (Oxford), 48(8): 916-9. [Abstract] [Full-text]
10. Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis.
    Rheumatology (Oxford), 48(8): 899-905. [Abstract] [Full-text]
11. Missed opportunities in the treatment of elderly patients with rheumatoid arthritis.
    Rheumatology (Oxford), 48(8): 906-10. [Abstract] [Full-text]
12. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    Rheumatology (Oxford), 48(8): 867-71. [Abstract] [Full-text]
13. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia.
    Clin Immunol, 132(2): 145-52. [Abstract] [Full-text]
14. Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.
    PLoS One, 4(7): e6242. [Abstract] [Full-text]
15. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.
    Ann Rheum Dis, 68(8): 1285-9. [Abstract] [Full-text]
16. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
    Ann Rheum Dis, 68(8): 1277-84. [Abstract] [Full-text]
17. Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis.
    Ann Rheum Dis, 68(8): 1316-21. [Abstract] [Full-text]
18. Does low-field dedicated extremity MRI (E-MRI) reliably detect bone erosions in rheumatoid arthritis? A comparison of two different E-MRI units and conventional radiography with high-resolution CT scanning.
    Ann Rheum Dis, 68(8): 1296-302. [Abstract] [Full-text]
19. Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis.
    Ann Rheum Dis, 68(8): 1271-6. [Abstract] [Full-text]
20. The sensitivity to change for lower disease activity is greater than for higher disease activity in rheumatoid arthritis trials.
    Ann Rheum Dis, 68(8): 1255-9. [Abstract] [Full-text]
21. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Ann Rheum Dis, 68(8): 1247-54. [Abstract] [Full-text]
22. Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.
    Ann Rheum Dis, 68(8): 1328-33. [Abstract] [Full-text]
23. Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.
    Ann Rheum Dis, 68(8): 1340-4. [Abstract] [Full-text]
24. Does practice mirror the evidence base in the treatment of rheumatoid arthritis?
    Clin Rheumatol, 28(8): 961-70. [Abstract] [Full-text]
25. Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.
    Clin Rheumatol, 28(8): 931-46. [Abstract] [Full-text]
26. Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab.
    Clin Rheumatol, 28(8): 985-8. [Abstract] [Full-text]
27. Association of the -1082 G/A promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis.
    Clin Rheumatol, 28(8): 899-905. [Abstract] [Full-text]
28. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Lancet, 374(9685): 210-21. [Abstract] [Full-text]
29. A quantitative analysis of sonographic images of the salivary gland: a comparison between sonographic and sialographic findings.
    Ultrasound Med Biol, 35(8): 1257-64. [Abstract] [Full-text]
30. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques.
    Eur J Nutr, 48(5): 315-22. [Abstract] [Full-text]
31. Longitudinal analysis of complementary and alternative health care use in children with juvenile idiopathic arthritis.
    Complement Ther Med, 17(4): 208-15. [Abstract] [Full-text]
32. Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis.
    Scand J Immunol, 70(2): 136-40. [Abstract] [Full-text]
33. A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period.
    Vaccine, 27(37): 5041-2. [Abstract] [Full-text]
34. CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6.
    Cytokine, 47(2): 112-8. [Abstract] [Full-text]
35. Mind and body management strategies for chronic pain and rheumatoid arthritis.
    Qual Health Res, 19(8): 1037-49. [Abstract] [Full-text]
36. Mesenteric rheumatoid nodules masquerading as an intra-abdominal malignancy: a case report and review of the literature.
    World J Surg Oncol, 7: 59. [Abstract] [Full-text]
37. CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups.
    J Cell Physiol, 221(1): 154-60. [Abstract] [Full-text]
38. Characterization of synovial tissue from arthritis patients: a proton magnetic resonance spectroscopic investigation.
    Rheumatol Int, 29(10): 1205-11. [Abstract] [Full-text]
39. Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-alpha.
    Rheumatol Int, 29(10): 1161-8. [Abstract] [Full-text]
40. Deforming arthropathy in SLE: review in the literature apropos of one case.
    Rheumatol Int, 29(10): 1219-21. [Abstract] [Full-text]
41. Response surface optimization of polysaccharides extraction from Liriope roots and its modulatory effect on Sjogren syndrome.
    Int J Biol Macromol, 45(3): 284-8. [Abstract] [Full-text]
42. Longitudinal changes in rheumatoid arthritis after rituximab administration assessed by quantitative and dynamic contrast-enhanced 3-T MR imaging: preliminary findings.
    Eur Radiol, 19(9): 2217-24. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.